893734-49-1

Basic information

• Product Name: 3-FLUORO-4'-METHOXY[1,1'-BIPHENYL]-4-AMINE
• Synonyms: 3-FLUORO-4'-METHOXY[1,1'-BIPHENYL]-4-AMINE;AKOS BAR-0918
• CAS NO: 893734-49-1
• Molecular Formula: C13H12FNO
• Molecular Weight: 217.24
• Mol File: 893734-49-1.mol

Chemical Properties

• Boiling Point: 336.8±32.0 °C(Predicted)
• Appearance: /
• Density: 1.172±0.06 g/cm3(Predicted)
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 2.83±0.10(Predicted)
• CAS DataBase Reference: 3-FLUORO-4'-METHOXY[1,1'-BIPHENYL]-4-AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-FLUORO-4'-METHOXY[1,1'-BIPHENYL]-4-AMINE(893734-49-1)
• EPA Substance Registry System: 3-FLUORO-4'-METHOXY[1,1'-BIPHENYL]-4-AMINE(893734-49-1)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 893734-49-1(Hazardous Substances Data)

Upstream product

• 367-24-8 4-bromo-2-fluoroaniline 
• 5720-07-0 4-methoxyphenylboronic acid 
• 29632-74-4 2-fluro-4-iodoaniline 

Relevant articles and documents

Discovery of a novel series of DHODH inhibitors by a docking procedure and QSAR refinement

A novel series of DHODH inhibitors was developed based on a lead which was obtained by a docking procedure and a medicinal chemistry exploration. The activity of the initial lead was improved by a QSAR method to yield low nanomolar inhibitors.

Structural optimization and structure–activity relationship of 4-thiazolidinone derivatives as novel inhibitors of human dihydroorotate dehydrogenase

Human dihydroorotate dehydrogenase (hDHODH), one of the attractive targets for the development of immunosuppressive drugs, is also a potential target of anticancer drugs and anti-leukemic drugs. The development of promising hDHODH inhibitors is in high demand. Based on the unique binding mode of our previous reported 4-thiazolidinone derivatives, via molecular docking method, three new series 4-thiazolidinone derivatives were designed and synthesized as hDHODH inhibitors. The preliminary structure–activity relationship was investigated. Compound 9 of biphenyl series and compound 37 of amide series displayed IC50 values of 1.32 μM and 1.45 μM, respectively. This research will provide valuable reference for the research of new structures of hDHODH inhibitors.

Trimethoxybenzanilide-based P-glycoprotein modulators: An interesting case of lipophilicity tuning by intramolecular hydrogen bonding

One of the principal reasons for the chemotherapy failure is the overexpression of drug efflux pumps, ABCB1 (also known as MDR1 or P-gp) and ABCC1 (also known as MRP1), whose inhibition remains a priority to circumvent drug resistance. We have recently sh